Učitavanje...
Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network
BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...
Spremljeno u:
| Izdano u: | BMC Health Serv Res |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939632/ https://ncbi.nlm.nih.gov/pubmed/27401940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-016-1477-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|